Influence of c-Myc and bcl-2 CO-expression on Proliferation, Apoptosis and Survival in CHO Cultures

  • Vasiliki Ifandi
  • Mohamed Al-Rubeai

Abstract

Under the constitutive control of c-Myc over-expression the CHO cultures showed an increase in growth rate and maximum cell number accompanied by a similar decrease in specific glucose consumption rate. Additionally overexpression of c-Myc appeared to induce morphological transformation and partial anchorage-independence. Although, the c-myc transfected cell line exhibited apoptosis at much lower rates than it is widely reported and associated with the over-expression of c-Myc, it was nevertheless apparent that c-Myc was responsible for the induction of higher apoptotic rates when compared with the control cell line. Hence, the anti-apoptotic gene bcl-2 was also used to transfect the c-Myc CHO cell line, in order to reduce cell death. Over-expression of both oncoproteins resulted in a cell line that exhibited higher proliferation rates and maximum cell numbers, with a decrease in apoptosis when compared to the parental cell line.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., and Korsmeyer, S.J., (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348: 334–336CrossRefGoogle Scholar
  2. Ifandi, V.; Al-Rubeai, M. Stable transfection of CHO cells with the c-myc gene results in increased proliferation rates, reduces serum dependency, and induces anchorage independence. Cytotechnology, 2003, 41, 1–10.CrossRefGoogle Scholar
  3. Simpson N, A. E. Milner, M. Al-Rubeai (1997) Prevention of hybridoma cell death by bcl-2 during sub-optimal culture conditions. Biotechnology and Bioengineering 54, 1–16.CrossRefGoogle Scholar
  4. Singh, R.P., Al-Rubeai, M., and Emery, A.N., (1996). Apoptosis: exploiting novel pathways to the improvement of cell culture processes. Genet. Eng, Biotech, 16: (4): 227–251.Google Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Vasiliki Ifandi
    • 1
  • Mohamed Al-Rubeai
    • 2
  1. 1.Biomedical Research InstituteUniversity of WarwickCoventryUK
  2. 2.Dept. of Chemical and Biochemical Engineering, and Centre for Synthesis and Chemical BiologyUniversity College DublinDublin 4Ireland

Personalised recommendations